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ABSTRACT: 
The human requirement for vitamin D is achieved primarily through the synthesis of this pre-
hormone in the skin during exposure to UVB radiation, with only a minor contribution from 
the diet year-round.   Achieving optimal vitamin D status is therefore largely dependent upon 
adequate exposure of the skin to sunlight, however the length of exposure required varies 
with latitude and season, and is also dependent upon skin pigmentation with darker skin 
requiring greater exposure than fair skin due to the protective effects of melanin against 
ultraviolet B (UVB) radiation. In northern European latitudes, where UVB radiation between 
the months of October and March is of insufficient intensity for the synthesis of vitamin D via 
this route, vitamin D deficiency is a public health concern, particularly for South Asian 
diaspora and other dark skinned ethnic minority communities.  The consequences of vitamin 
D deficiency include poor bone health, including rickets and osteomalacia. In addition there 
is increasing awareness of an important role for vitamin D in the development and 
progression of chronic diseases including type 2 diabetes which is prevalent in South Asian 
populations.  The aim of this review is to examine some of the most recent reports of vitamin 
D status in South Asian diaspora communities, and to explore its  impact on bone health.  In 
addition, we will examine the putative association between type 2 diabetes and vitamin D 
deficiency in South Asian populations and the current guidelines for treatment of vitamin D 
deficiency of South Asians in primary care settings. .  
KEYWORDS: South Asian, vitamin D, bone health, insulin resistance, diabetes 
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Vitamin D can be obtained from diet (oily fish and liver oils), however the human requirement 
for vitamin D is achieved primarily through the synthesis of this pre-hormone in the skin 
during exposure to ultraviolet B (UVB) radiation, with only a minor contribution from the diet 
year-round [Ashwell et al., 2010, Darling et al., 2013]. Vitamin D status is assessed by 
measuring 25 hydroxy vitamin D (25(OH)D) levels circulating in the blood plasma or serum.   
Although there has been much debate over the definition of adequate and optimal vitamin D 
status based on blood 25(OH)D levels, there is general consensus that values <25 nmol/L 
(10ng/ml) indicate deficiency and ≥50 nmol/L (20ng/ml) indicate sufficiency.  The variations 
to this proposed by different international expert  panels are effectively summarised by Spiro 
and Buttriss (2014) [Spiro et al., 2014]. 
   
The potential consequences of vitamin D deficiency are wide-ranging. Vitamin D receptors 
are present in many cell types and almost every human tissue, and vitamin D is an important 
regulator of the expression of genes regulating key metabolic processes. It is not surprising 
therefore, that deficiency has been linked to increased prevalence of a broad range of medical 
conditions, including muscular skeletal disorders, cardiovascular disease, cancer, 
autoimmune disorders and type 2 diabetes [Holick, 2007]. 
 
Achieving optimal vitamin D status is largely dependent upon adequate exposure of the skin 
to sunlight, however the length of exposure required varies with latitude and season. It is also 
dependent upon skin pigmentation with darker skin requiring greater exposure than fair skin 
because melanin absorbs UVB radiation in the 290-320nm range and functions as a light filter 
determining the amount of incident UV radiation available for the cutaneous production of 
previtamin D3 [Norman, 1998]. In northern European latitudes, UVB radiation between the 
months of October and March is of insufficient intensity for the synthesis of vitamin D via this 
route, thus deficiency is of public health concern, particularly for South Asian (SA) diaspora 
(defined as people originating from India, Pakistan, Sri-Lanka, Bangladesh) and other darker 
skinned ethnic minority communities in the UK [Mavroeidi et al., 2010, Patel et al., 2013].  
 
Risk factors for SA communities in the UK. 
Vitamin D deficiency is estimated to affect the majority of the UK SA population, with one 
report suggesting that this may be as high as 94% of the SA population in the winter, and 82 
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% in the summer [Pal et al., 2003].  This high prevalence can be accounted for by  several risk 
factors that are particular to the SA population,  including poor dietary intake of vitamin D as 
many SAs in the UK follow religions with an emphasis on a vegetarian diet, which is low in 
vitamin D content [Dobbs J, 2006]. However some Bangladeshi populations may have a lower 
prevalence of deficiency due to a diet that includes the regular consumption of oily fish.  The 
protective effect of melanin in SA skin that limits cutaneous vitamin D synthesis is 
compounded by the cultural needs to cover the body amongst many SA women. Studies 
conducted around the world report lower vitamin D status in veiled women compared to 
males or females adopting Western dress [Alshishtawy, 2012], however  sun avoidance when 
outside is common to both male and female SA adults.  Kift et al [Kift et al., 2013] conducted 
a prospective cohort study comparing the seasonal variation in vitamin D status in SA and 
white adults living in Manchester, UK over a 12 month period.   The study revealed a marked 
seasonal variation in both groups.  In summer, the median 25(OH)D level in the SA group was 
9.0 ng/ml, falling to 5.8 ng/ml in winter [Kift et al., 2013]. This compared with values in the 
white population of 26.2 ng/ml in summer and 18.9 ng/ml in winter. The majority of SAs never 
reached sufficiency in vitamin D status at any point during the year.  Ultraviolet (UV) 
dosimeters used to record personal UV exposure revealed lower UV exposure among SAs, 
despite spending similar amounts of time outdoors. Sun exposure diaries completed by the 
participants also reported lower amounts of skin surface exposure in the SA group suggesting 
sun avoidance when outside [Kift et al., 2013].  Other studies using simulated courses of 
summer sunlight in SA adults in controlled dosimetric conditions have confirmed the efficacy 
of sunlight exposure doses equivalent to 45 minutes of  unshaded noontime summer sunlight 
at 53.5°N (Manchester, United Kingdom) in raising vitamin D status [Farrar et al., 2011, Farrar 
et al., 2013]. While it has been reported that a higher dose of UV radiation is required to 
increase plasma 25(OH)D concentration in SAs than Caucasians, the capacity to produce 
vitamin D is no different between the two ethnic groups [Lo et al., 1986].   
Bone Health 
Despite the well- established mechanistic link between vitamin D, parathyroid hormone (PTH) 
and calcium homeostasis described in other papers within this special edition of Therapeutic 
Advances in Musculoskeletal Diseases, evidence for an impact of poor vitamin D status on 
bone health in UK SA populations is conflicting.  
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Observational studies exploring the relationship between vitamin D status, bone quality and 
biochemical markers of bone turnover have been undertaken.  Lowe et al [Lowe et al., 2010], 
studied the vitamin D status and markers of bone turnover in postmenopausal Caucasian and 
SA women living in the UK. Bone quality was assessed using broadband ultrasound 
attenuation. Although the SA women had significantly higher serum PTH and lower 25(OH)D 
concentrations than Caucasian women, this was not associated with significantly higher 
markers of bone resorption, or reduced bone quality in the SA women.  Similar results were 
reported by Patel et al [Patel et al., 2013]  who undertook a large cross sectional study 
examining vitamin D status and numerous health outcomes including osteoporosis in UK 
minority ethnic groups.  The study included over one thousand SA adults, aged > 45 years 
recruited from 20 primary care practices in Birmingham, UK.  Severe vitamin D deficiency 
(25(OH)D < 6ug/l) was reported in 42% of the SA participants, however poor vitamin D status 
was not found to be associated with elevated incidence of osteoporosis, measured using Dual 
X-ray Absorptiometry (DXA),  in this ethnic group [Patel et al., 2013]. In contrast, in a study of 
young SA women living in the UK (mean age 29 years)  [Roy et al., 2007] , DXA revealed that 
a decrease in serum 25(OH)D of ≤ 15ng/ml was associated with a reduction in bone mass at 
the hip and wrist.  
 
Intervention studies have also been undertaken to examine the effect of vitamin D 
supplementation of deficient women on bone health.  In a randomised control trial conducted 
in postmenopausal SA women, Von Hurst [Von Hurst et al., 2010] reported that vitamin D 
supplementation (4000 IU (100 µg) vitamin D3 daily) significantly increased serum 25(OH)D 
from Median (25th, 75th percentiles) 21 (11, 40) to 75 (55, 84) nmol/l,  and this was associated 
with  significantly lower markers of bone resorption compared to the placebo control group. 
They concluded that correcting vitamin D deficiency in older women suppresses the age-
induced increase in bone turnover and reduces bone resorption which would normally be 
exacerbated in conditions of low serum 25(OH)D  [Von Hurst et al., 2010]. A recent study 
examining tibial tenderness as a diagnostic measure of vitamin D status also reported a 
positive improvement in tenderness score following high dose vitamin D supplementation 
(1.8 million IU (45 mg) of vitamin D3 in split doses), in Pakistani women at high risk for 
deficiency [Ali et al., 2013].  
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As mentioned previously, 25(OH)D status exhibits marked seasonal variation, however this 
variation in muted in SA women, due to reduced sunlight exposure during the summer 
months. Darling et al [Darling et al., 2014] hypothesised that a high degree of seasonal cycling 
of 25(OH)D increased bone resorption, and conducted a longitudinal study of SA and  
Caucasian women in which 25(OH)D was measured once per season, along with PTH and C-
terminal telopetide of type 1 collagen (CTX) which is released during the resorption of mature 
bone.  The study confirmed this hypothesis, revealing that the amplitude of the seasonal 
change in 25(OH)D was positively associated with elevated PTH and CTX [Darling et al., 2014].  
This finding also concurs with the hypothesis put forward by Vieth that large seasonal 
fluctuations in 25(OH)D are associated with adverse health outcomes [Vieth, 2004].   
Type 2 diabetes mellitus  
Vitamin D deficiency is prevalent in diabetic patients, and could be as high as in 91% patients 
with diabetes [Alam et al., 2012].  While this observation is not evidence for a causal link,   
vitamin D specific receptors have been identified in β-pancreatic cells [Mathieu et al., 2005] 
and there is some evidence suggesting  a crucial role for vitamin D status in the pathogenesis 
of type 2 diabetes mellitus (T2DM), via  direct and indirect mechanisms that impact on β-cell 
function [Pittas et al., 2007] . However the evidence from human studies remains conflicting. 
   
A systematic review undertaken by Mitri et al in 2011 [Mitri et al., 2011] examined both 
longitudinal observations studies of vitamin D status and randomized controlled trials (RCTs) 
of vitamin D  supplementation on glycemic outcomes.  Meta-analysis of the longitudinal data 
from three observational cohort studies revealed that there was a statistically significant 
overall reduction in relative risk of the development of newly diagnosed T2DM in those who 
consumed >12.6 µg/day compared with those who consumed <5/ µg/day.   Combining data 
from 5 cohort studies that measured baseline blood 25(OH)D concentration revealed that 
there was a significant inverse relationship between blood 25(OH)D and risk of developing 
T2DM, with individuals with a 25(OH)D >25ng/ml having a 43% lower risk than those with 
25(OH)D <14 ng/ml [Mitri et al., 2011]. This observation was confirmed in a recent 
prospective observational study of prediabetic patients in the USA, after adjusting for other 
lifestyle factors [Pittas et al., 2012].  Mitri [Mitri et al., 2011] undertook summary of the data 
from 3 RCTs identified by the systematic search that examined the impact of infrequent, high 
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dose vitamin D supplementation (100,000 IU given once;  40,000 IU/week for 26 weeks;  
100,000 or 200,000 IU given once)  in patients with established T2DM. The analysis revealed 
no improvement in the glycaemic indicators in these patients. In addition, summarising data 
from 4 RCTs that examined the impact of vitamin D supplementation (doses ranging from 
5714 to 8571 IU/day) on insulin resistance in participants with normal glucose tolerance 
revealed no significant effect, with the exception of one trial [Von Hurst et al., 2010] that 
reported an improvement in insulin resistance following vitamin D supplementation (4000 
IU/day) in non-diabetic, SA women with insulin resistance at baseline.  Taken together, this 
indicates that there is an inverse relationship between vitamin D status and risk of developing 
T2DM, however “normalising” vitamin D status through supplementation in patients with 
established T2DM does not improve glycaemic outcomes, however there may be some 
genetically determined differences in this glycaemic response to supplementation that also 
involves parathyroid hormone (PTH) and Ca metabolism [Jain et al., 2012]. 
 
Studies in SA populations with T2DM. 
South Asian communities have a 4-6 fold greater rate of persons with T2DM than white British 
communities, [Barnett et al., 2006] and there have been a number of recent studies 
investigating the relationship with vitamin D status and T2DM in this ethnic group.   A small 
cross sectional study conducted in SA in the UK revealed a significantly higher prevalence of 
hypovitaminosis (defined as a 25-hydroxyvitamin D < 50 nmol/l) in with T2DM (83%) 
compared to the non- diabetic control group (70%), although there was no difference in the 
prevalence of vitamin D deficiency (defined as 25-hydroxyvitamin D <12.5 nmol/l) between 
the two groups (13% vs 19% respectively) [Tahrani et al., 2010].  In addition, there were no 
overall significant differences in the mean HbA1c levels between patients with and without 
vitamin D deficiency, however vitamin D deficient women did have higher glycated 
haemoglobin (HbA1c) levels than the rest of the diabetic cohort.  Linear regression analysis 
revealed that vitamin D deficiency was independently related to HbA1c in women with T2DM, 
but not in men [Tahrani et al., 2010].  
 
Metabolic syndrome, (a condition that includes insulin resistance, visceral adiposity, 
atherogenic dyslipidemia and endothelial dysfunction [Huang, 2009]) is also prevalent in SA 
populations.  George et al [George et al., 2013] examined the association between 25(OH)D 
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and PTH with metabolic syndrome in SA (Indian) adults living in South Africa to determine 
whether ethnic differences in 25(OH)D levels or PTH levels contribute to difference in the 
prevalence of metabolic syndrome.  The study revealed that SAs had significantly higher 
fasting glucose, lower 25(OH)D levels and were more insulin resistant than non SAs. The 
prevalence of vitamin D deficiency (<30 nmol/l) was 3% in African and 15% in SA. The 
prevalence of metabolic syndrome was higher in the SA’s (46%), compared to Africans (19%), 
however no statistically significant association between vitamin D status, and metabolic 
syndrome or its components was identified [George et al., 2013].   Similarly, a study in Oslo 
Norway was undertaken to examine the reason for the greater prevalence of insulin 
resistance and T2DM in people of SA ethnicity [Wium et al., 2013]. Vitamin D deficient 
patients (25(OH)D≤ 50 nmol/l) with T2DM were recruited, 43 of northern European origin and  
19 SA.  There was evidence of ethnic differences in fasting endogenous glucose production, 
with higher levels found in SA, however there was no significant correlation between 25(OH)D 
and insulin sensitivity or insulin secretion in either ethnic group or in the cohort as a whole 
[Wium et al., 2013].    
 
Gestational diabetes is also more prevalent in SA women than in Caucasian women  [Gunton 
et al., 2001]. Whitelaw et al [Whitelaw et al., 2014] undertook a cross sectional study in UK 
pregnant women undergoing glucose tolerance testing at 26 weeks gestation to explore 
potential links between lower vitamin D status, ethnicity and glucose metabolism during 
pregnancy. Of the 1467 women included in the study, 53.4% of the women were of SA origin, 
with 40.6% describing themselves as European (including British). The selection criteria 
excluded women with pre-gestational diabetes. Vitamin D status, PTH levels, plasma glucose 
and serum insulin and calcium were included in the biochemical analyses. Vitamin D status 
was significantly higher in the European compared to the SA women, with 93% of SA and 66% 
of European women deficient (25(OH)D<20 ng/ml) [Whitelaw et al., 2014].  Fasting and post 
challenge glucose and fasting insulin concentrations were lower among European women 
than SA women, however there were no statistically significant associations between,  
vitamin D status and glucose tolerance in pregnancy, and it was concluded that lower 25(OH)D 
does not explain ethnic differences in the risk of gestational diabetes.  However, some 
interesting associations between serum calcium and fasting insulin and the risk of developing 
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gestational diabetes were noted, irrespective of ethnicity in this cohort [Whitelaw et al., 
2014].   
 
Combinations of calcium and vitamin D have also been studied. One of the largest 
observational studies was the Women’s Health Initiative study of 33,951 receiving calcium 
(1000 mg) plus vitamin D (400 IU) supplements daily, revealed there was no reduction in the 
risk of developing diabetes over 7 years [De Boer et al., 2008].  It is not stated in this study 
how many of the participants were South Asian, however 2% were stated as being of 
Asian/Pacific Island which would include the South Asian sub group).  Interestingly, a study 
conducted in the UK [Sabherwal et al., 2010] investigated the effect of vitamin D and calcium 
supplementation on glycemic control in SA patients with established T2DM and vitamin D 
inadequacy.  A total of 52 patients diagnosed with T2DM for more than 3 years were included 
in this study.  A baseline, 29 were vitamin D deficient (<25 nmol/l) and 23 insufficient (≤50 
nmol/l).  Supplementation with 10 µg/day (400 IU) vitamin D and 1200 mg Ca/day resulted 
an increase in serum 25(OH)D to normal levels, and a  decrease in glycated haemoglobin,  
HbA1c.  There was a significant negative correlation between change in Hb1Ac and change in 
vitamin D levels post treatment (r-0.305) suggesting that vitamin D replacement therapy 
combined with Ca may be beneficial for glycaemic control in SA patients [Sabherwal et al., 
2010].  
Management of vitamin D deficiency in South Asians within the primary care setting  
In 2012, the Chief Medical Officers for the United Kingdom sent out a letter to General 
Practitioners, Practice Nurses Health Visitors and Community Pharmacists to raise the 
awareness of vitamin D deficiency particularly amongst the high risk groups in the UK 
population, which  includes  people who have darker skin of  SA origin [Chief Medical Officers 
for the United Kingdom, 2012] . They recommended that these group of patients should take 
a daily supplement containing 10μg (400 IU) of vitamin D.   This has recently been confirmed 
by the Scientific Advisory Committee on Nutrition (SACN) in the most recent (2016) report on 
vitamin D and health [Sacn, 2016] in which a reference nutrient intakes (RNI) of 10 μg per day 
is now recommended for all over the age of 4 years, including “population groups at increased 
risk of vitamin D deficiency”.  Recognising that this is difficult to achieve from natural dietary 
sources unless oily fish is consumed daily, Public Health England also suggests that people 
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from at risk groups, including darker skinned ethnic minorities, should consider taking a daily 
supplement of 10 μg throughout the year. 
 
In 2014 the National Institute for Health and Care Excellence (NICE) released guidelines 
entitled “Vitamin D: increasing supplement use in at-risk groups” [National Institute for 
Health and Care Excellence, 2014]. The “at risk” group included those who have low or no 
exposure to the sun including those who cover their skin for cultural reasons and people with 
darker skin, including SAs. The emphasis in this guideline is around a multi agency approach 
in raising the awareness of vitamin D deficiency, the increased availability of Vitamin D 
products, and recommending that suitable supplements should be available to people with 
particular dietary needs (for example, people who avoid nuts, are vegan or have a halal or 
kosher diet). Testing of vitamin D status if someone has symptoms of deficiency or is at very 
high risk was also recommended.    
 
There is broad acceptance amongst healthcare professionals and Clinical Commissioning 
Groups (CCGs) of the need to raise awareness of Vitamin D deficiency, not only amongst the 
healthcare professionals, but also in the UK population, and a general consensus that there is 
no need to test the vitamin D status routinely in asymptomatic patients. In symptomatic 
patients, there is a need to measure the vitamin D status if one or more other risk factors are 
present.  The loading dose and maintenance dose of vitamin D can then be prescribed based 
on  the status of the individual. An example of a typical flowchart produced by CCGs to guide 
non-specialist clinicians through the diagnosis and treatment of vitamin D deficiency is shown 
in figure 1. This example is taken from the Lancashire Medicines Management Group [Smith, 
2013]. 
 
Insert Figure 1 here 
 
As most guidelines do not recommend the testing of vitamin D status in asymptomatic adults, 
SAs remain at high risk of deficiency and potential longer term sequela due to the very high 
prevalence of vitamin D deficiency in this population, with most individuals remaining 
asymptomatic. However the most recent SACN report raises the RNI from 0 (1991) to 10 µg/d 
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for all individuals aged 4 years and above [SACN, 2016].  Current guidelines recommend 
prevention through advice on regular sunlight exposure, dietary sources of vitamin D and use 
of “over the counter” vitamin D supplements,  giving patient control of vitamin D 
supplementation. The choice of product should be led by patient preference taking into 
consideration their beliefs. One specific example is gelatine which is usually derived from pigs 
and commonly used to encapsulate medications and supplements.   In Islam, any products 
derived from pigs are considered to be unlawful, or “not Halal”. Where there is no choice 
regarding products containing gelatine there is a statement from WHO that permits Muslims 
to take medicines encapsulated by gelatine, however this still remains a contentious issue 
amongst Islamic leaders and scholars.  
 
Summary 
While there is compelling evidence for an association between vitamin D deficiency and 
chronic conditions including poor bone health and T2DM, all of which are prevalent in SA 
ethnic minority groups in the UK, unequivocal evidence of a causal mechanism remains 
elusive.  The most recent reports from SACN and Public Health England recommend that in 
order to protect musculoskeletal health, serum 25(OH)D should not fall below 25 nmol/l, and 
that intakes of 10 µg per day are recommended for the UK population over 4 years of age. For 
SA ethnic minority groups in the UK, meeting these recommendations is likely to require the 
use of vitamin D supplements year round. New patient care guidelines for non-specialists are 
required to emphasise this in the primary care setting. 
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